Aging and adipose tissue: Potential interventions for diabetes and regenerative medicine

Allyson K. Palmer, James L Kirkland

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Adipose tissue dysfunction occurs with aging and has systemic effects, including peripheral insulin resistance, ectopic lipid deposition, and inflammation. Fundamental aging mechanisms, including cellular senescence and progenitor cell dysfunction, occur in adipose tissue with aging and may serve as potential therapeutic targets in age-related disease. In this review, we examine the role of adipose tissue in healthy individuals and explore how aging leads to adipose tissue dysfunction, redistribution, and changes in gene regulation. Adipose tissue plays a central role in longevity, and interventions restricted to adipose tissue may impact lifespan. Conversely, obesity may represent a state of accelerated aging. We discuss the potential therapeutic potential of targeting basic aging mechanisms, including cellular senescence, in adipose tissue, using type II diabetes and regenerative medicine as examples. We make the case that aging should not be neglected in the study of adipose-derived stem cells for regenerative medicine strategies, as elderly patients make up a large portion of individuals in need of such therapies.

Original languageEnglish (US)
JournalExperimental Gerontology
DOIs
StateAccepted/In press - Jan 5 2016

Fingerprint

Regenerative Medicine
Medical problems
Adipose Tissue
Aging of materials
Tissue
Cell Aging
Stem Cells
Stem cells
Gene expression
Vascular Resistance
Type 2 Diabetes Mellitus
Insulin Resistance
Therapeutics
Obesity
Insulin
Inflammation
Lipids
Genes

Keywords

  • Adipose Tissue
  • Aging
  • Cellular Senescence
  • Insulin Resistance
  • Preadipocyte
  • Stem Cell

ASJC Scopus subject areas

  • Aging
  • Biochemistry
  • Cell Biology
  • Endocrinology
  • Genetics
  • Molecular Biology

Cite this

Aging and adipose tissue : Potential interventions for diabetes and regenerative medicine. / Palmer, Allyson K.; Kirkland, James L.

In: Experimental Gerontology, 05.01.2016.

Research output: Contribution to journalArticle

@article{213634b52a2b4d00b7ce31e9f387a3b5,
title = "Aging and adipose tissue: Potential interventions for diabetes and regenerative medicine",
abstract = "Adipose tissue dysfunction occurs with aging and has systemic effects, including peripheral insulin resistance, ectopic lipid deposition, and inflammation. Fundamental aging mechanisms, including cellular senescence and progenitor cell dysfunction, occur in adipose tissue with aging and may serve as potential therapeutic targets in age-related disease. In this review, we examine the role of adipose tissue in healthy individuals and explore how aging leads to adipose tissue dysfunction, redistribution, and changes in gene regulation. Adipose tissue plays a central role in longevity, and interventions restricted to adipose tissue may impact lifespan. Conversely, obesity may represent a state of accelerated aging. We discuss the potential therapeutic potential of targeting basic aging mechanisms, including cellular senescence, in adipose tissue, using type II diabetes and regenerative medicine as examples. We make the case that aging should not be neglected in the study of adipose-derived stem cells for regenerative medicine strategies, as elderly patients make up a large portion of individuals in need of such therapies.",
keywords = "Adipose Tissue, Aging, Cellular Senescence, Insulin Resistance, Preadipocyte, Stem Cell",
author = "Palmer, {Allyson K.} and Kirkland, {James L}",
year = "2016",
month = "1",
day = "5",
doi = "10.1016/j.exger.2016.02.013",
language = "English (US)",
journal = "Experimental Gerontology",
issn = "0531-5565",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Aging and adipose tissue

T2 - Potential interventions for diabetes and regenerative medicine

AU - Palmer, Allyson K.

AU - Kirkland, James L

PY - 2016/1/5

Y1 - 2016/1/5

N2 - Adipose tissue dysfunction occurs with aging and has systemic effects, including peripheral insulin resistance, ectopic lipid deposition, and inflammation. Fundamental aging mechanisms, including cellular senescence and progenitor cell dysfunction, occur in adipose tissue with aging and may serve as potential therapeutic targets in age-related disease. In this review, we examine the role of adipose tissue in healthy individuals and explore how aging leads to adipose tissue dysfunction, redistribution, and changes in gene regulation. Adipose tissue plays a central role in longevity, and interventions restricted to adipose tissue may impact lifespan. Conversely, obesity may represent a state of accelerated aging. We discuss the potential therapeutic potential of targeting basic aging mechanisms, including cellular senescence, in adipose tissue, using type II diabetes and regenerative medicine as examples. We make the case that aging should not be neglected in the study of adipose-derived stem cells for regenerative medicine strategies, as elderly patients make up a large portion of individuals in need of such therapies.

AB - Adipose tissue dysfunction occurs with aging and has systemic effects, including peripheral insulin resistance, ectopic lipid deposition, and inflammation. Fundamental aging mechanisms, including cellular senescence and progenitor cell dysfunction, occur in adipose tissue with aging and may serve as potential therapeutic targets in age-related disease. In this review, we examine the role of adipose tissue in healthy individuals and explore how aging leads to adipose tissue dysfunction, redistribution, and changes in gene regulation. Adipose tissue plays a central role in longevity, and interventions restricted to adipose tissue may impact lifespan. Conversely, obesity may represent a state of accelerated aging. We discuss the potential therapeutic potential of targeting basic aging mechanisms, including cellular senescence, in adipose tissue, using type II diabetes and regenerative medicine as examples. We make the case that aging should not be neglected in the study of adipose-derived stem cells for regenerative medicine strategies, as elderly patients make up a large portion of individuals in need of such therapies.

KW - Adipose Tissue

KW - Aging

KW - Cellular Senescence

KW - Insulin Resistance

KW - Preadipocyte

KW - Stem Cell

UR - http://www.scopus.com/inward/record.url?scp=84959440332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959440332&partnerID=8YFLogxK

U2 - 10.1016/j.exger.2016.02.013

DO - 10.1016/j.exger.2016.02.013

M3 - Article

C2 - 26924669

AN - SCOPUS:84959440332

JO - Experimental Gerontology

JF - Experimental Gerontology

SN - 0531-5565

ER -